GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Degree of Operating Leverage

Remus Pharmaceuticals (NSE:REMUS) Degree of Operating Leverage : 0.31 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Remus Pharmaceuticals's Degree of Operating Leverage for the quarter that ended in Mar. 2025 was 0.31. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for Remus Pharmaceuticals's Degree of Operating Leverage or its related term are showing as below:

NSE:REMUS's Degree of Operating Leverage is ranked better than
62.16% of 111 companies
in the Medical Distribution industry
Industry Median: 0.89 vs NSE:REMUS: 0.31

Remus Pharmaceuticals Degree of Operating Leverage Historical Data

The historical data trend for Remus Pharmaceuticals's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Degree of Operating Leverage Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24 Mar25
Degree of Operating Leverage
- 0.43 6.83 - 0.31

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24 Mar25
Degree of Operating Leverage Get a 7-Day Free Trial 6.83 - - 0.22 0.31

Competitive Comparison of Remus Pharmaceuticals's Degree of Operating Leverage

For the Medical Distribution subindustry, Remus Pharmaceuticals's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remus Pharmaceuticals's Degree of Operating Leverage Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's Degree of Operating Leverage falls into.


;
;

Remus Pharmaceuticals Degree of Operating Leverage Calculation

Remus Pharmaceuticals's Degree of Operating Leverage for the quarter that ended in Mar. 2025 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 488 (Mar. 2025) / 306.7 (Mar. 2024) - 1 )/( 6203.6 (Mar. 2025) / 2129.4 (Mar. 2024) - 1 )
=0.5911/1.9133
=0.31***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Remus Pharmaceuticals  (NSE:REMUS) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


Remus Pharmaceuticals Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Remus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines